Does TORIPALIMAB Cause Platelet count decreased? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Platelet count decreased have been filed in association with TORIPALIMAB (LOQTORZI). This represents 3.9% of all adverse event reports for TORIPALIMAB.
53
Reports of Platelet count decreased with TORIPALIMAB
3.9%
of all TORIPALIMAB reports
3
Deaths
30
Hospitalizations
How Dangerous Is Platelet count decreased From TORIPALIMAB?
Of the 53 reports, 3 (5.7%) resulted in death, 30 (56.6%) required hospitalization, and 15 (28.3%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Diarrhoea (50)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which TORIPALIMAB Alternatives Have Lower Platelet count decreased Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN